-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Ventyx Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q2 2024.
- Ventyx Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$35.7M, a 37.5% increase year-over-year.
- Ventyx Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$186M, a 9.48% decline year-over-year.
- Ventyx Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$208M, a 83.8% decline from 2022.
- Ventyx Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$113M, a 68.5% decline from 2021.
- Ventyx Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$67.1M, a 852% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)